These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 14504378)

  • 21. Neuroprotection and dopamine agonists.
    Schapira AH
    Neurology; 2002 Feb; 58(4 Suppl 1):S9-18. PubMed ID: 11909981
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Contemporary approaches to the pharmacotherapeutic management of Parkinson's disease: an overview.
    Stern MB
    Neurology; 1997 Jul; 49(1 Suppl 1):S2-9. PubMed ID: 9222270
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Neuroprotection in idiopathic Parkinson's disease.
    Reichmann H
    J Neurol; 2002 Oct; 249 Suppl 3():III/21-3. PubMed ID: 12522567
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Are dopamine receptor agonists neuroprotective in Parkinson's disease?
    Le WD; Jankovic J
    Drugs Aging; 2001; 18(6):389-96. PubMed ID: 11419913
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Neuroprotection in Parkinson disease: mysteries, myths, and misconceptions.
    Schapira AH; Olanow CW
    JAMA; 2004 Jan; 291(3):358-64. PubMed ID: 14734599
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dopamine D1 receptor agonists as antiparkinson drugs.
    Mailman RB; Nichols DE
    Trends Pharmacol Sci; 1998 Jul; 19(7):255-6. PubMed ID: 9703756
    [No Abstract]   [Full Text] [Related]  

  • 27. Slowing Parkinson's disease progression: recent dopamine agonist trials.
    Ahlskog JE
    Neurology; 2003 Feb; 60(3):381-9. PubMed ID: 12580184
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Agonists versus levodopa in PD: the thrilla of whitha.
    Montgomery EB
    Neurology; 2003 Nov; 61(10):1462; author reply 1462-3. PubMed ID: 14638991
    [No Abstract]   [Full Text] [Related]  

  • 29. Agonists vs levodopa in PD: the thrilla of whitha.
    Wooten GF
    Neurology; 2003 Feb; 60(3):360-2. PubMed ID: 12578913
    [No Abstract]   [Full Text] [Related]  

  • 30. The role of dopamine agonists in early Parkinson's disease.
    Watts RL
    Neurology; 1997 Jul; 49(1 Suppl 1):S34-48. PubMed ID: 9222273
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Do dopamine agonists provide neuroprotection?
    Yamamoto M
    Neurology; 1998 Aug; 51(2 Suppl 2):S10-2. PubMed ID: 9711974
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [The agonist of dopamine receptors piribedil in treatment of Parkinson's disease].
    Pilipovich AA; Golubev VL
    Zh Nevrol Psikhiatr Im S S Korsakova; 2017; 117(6):83-90. PubMed ID: 28745677
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Neuroprotection and dopamine agonists.
    Pirtosek Z; Flisar D
    Adv Exp Med Biol; 2004; 541():55-74. PubMed ID: 14977208
    [No Abstract]   [Full Text] [Related]  

  • 34. Parkinson's disease.
    Clarke C; Moore AP
    Clin Evid; 2002 Jun; (7):1208-20. PubMed ID: 12230738
    [No Abstract]   [Full Text] [Related]  

  • 35. Treatment of early Parkinson's disease. Part 2.
    Simuni T; Lyons KE; Pahwa R; Hauser RA; Comella C; Elmer L; Weintraub D
    Eur Neurol; 2009; 61(4):206-15. PubMed ID: 19176961
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Old and new dopamine agonists in Parkinson's disease. Proceedings of an international congress. Pisa, Italy, December 1993.
    J Neural Transm Suppl; 1995; 45():1-321. PubMed ID: 8847537
    [No Abstract]   [Full Text] [Related]  

  • 37. [Pharmacological profiles and clinical effects of ropinirole hydrochloride (ReQuip)].
    Arai H; Minami J
    Nihon Yakurigaku Zasshi; 2007 Oct; 130(4):313-9. PubMed ID: 17938518
    [No Abstract]   [Full Text] [Related]  

  • 38. Treatment options for early Parkinson's disease.
    Stacy M; Brownlee HJ
    Am Fam Physician; 1996 Mar; 53(4):1281-7. PubMed ID: 8629572
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Presentation].
    García-Ruiz PJ; Luquin MR; Martínez-Castrillo JC
    Rev Neurol; 2012; 55 Suppl 1():S1. PubMed ID: 23169226
    [No Abstract]   [Full Text] [Related]  

  • 40. [The early therapy challenge].
    Reichmann H
    Krankenpfl J; 2005; 43(7-10):240. PubMed ID: 16515310
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.